BlackRock’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.16M | Buy |
3,618,323
+3,591,013
| +13,149% | +$4.13M | ﹤0.01% | 3781 |
|
|
2025
Q1 | $40.7K | Hold |
27,310
| – | – | ﹤0.01% | 4908 |
|
|
2024
Q4 | $22.4K | Hold |
27,310
| – | – | ﹤0.01% | 5032 |
|
|
2024
Q3 | $22.3K | Hold |
27,310
| – | – | ﹤0.01% | 4876 |
|
|
2024
Q2 | $22.4K | Sell |
27,310
-24,336
| -47% | -$20K | ﹤0.01% | 4947 |
|
|
2024
Q1 | $41.8K | Buy |
51,646
+28,193
| +120% | +$22.8K | ﹤0.01% | 4848 |
|
|
2023
Q4 | $33.1K | Sell |
23,453
-288
| -1% | -$406 | ﹤0.01% | 4950 |
|
|
2023
Q3 | $27.8K | Sell |
23,741
-2,563
| -10% | -$3K | ﹤0.01% | 5028 |
|
|
2023
Q2 | $36.6K | Buy |
26,304
+7,448
| +39% | +$10.4K | ﹤0.01% | 5035 |
|
|
2023
Q1 | $26.4K | Buy |
18,856
+618
| +3% | +$865 | ﹤0.01% | 5136 |
|
|
2022
Q4 | $24.8K | Buy |
18,238
+412
| +2% | +$560 | ﹤0.01% | 5266 |
|
|
2022
Q3 | $28K | Sell |
17,826
-5,115
| -22% | -$8.03K | ﹤0.01% | 5371 |
|
|
2022
Q2 | $52K | Sell |
22,941
-44,624
| -66% | -$101K | ﹤0.01% | 5309 |
|
|
2022
Q1 | $227K | Buy |
67,565
+10,636
| +19% | +$35.7K | ﹤0.01% | 4987 |
|
|
2021
Q4 | $305K | Buy |
+56,929
| New | +$305K | ﹤0.01% | 4934 |
|